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Background: Tools to enhance physician searches of Medline and other bibliographic databases have potential to
improve the application of new knowledge in patient care. This is particularly true for articles about glomerular
disease, which are published across multiple disciplines and are often difficult to track down. Our objective was to
develop and test search filters for PubMed, Ovid Medline, and Embase that allow physicians to search within a
subset of the database to retrieve articles relevant to glomerular disease.
Methods: We used a diagnostic test assessment framework with development and validation phases. We read a
total of 22,992 full text articles for relevance and assigned them to the development or validation set to define the
reference standard. We then used combinations of search terms to develop 997,298 unique glomerular disease
filters. Outcome measures for each filter included sensitivity, specificity, precision, and accuracy. We selected optimal
sensitive and specific search filters for each database and applied them to the validation set to test performance.
Results: High performance filters achieved at least 93.8% sensitivity and specificity in the development set. Filters
optimized for sensitivity reached at least 96.7% sensitivity and filters optimized for specificity reached at least 98.4%
specificity. Performance of these filters was consistent in the validation set and similar among all three databases.
Conclusions: PubMed, Ovid Medline, and Embase can be filtered for articles relevant to glomerular disease in a
reliable manner. These filters can now be used to facilitate physician searching.
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Retrieving health literature is the cornerstone to
evidence-based practice. However, the sheer volume of
available information presents a challenge to even the
most skilled physicians and researchers. Many users lack
knowledge of information sources, have difficulty formu-
lating an optimal search strategy, and are short on time
[1-3]. These obstacles may be even greater when dealing
with an area of nephrology such as glomerular disease,
which is particularly broad, multidisciplinary, and diffi-
cult to define. Indexing of articles is often inconsistent,* Correspondence: amit.garg@lhsc.on.ca
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distribution, and reproduction in any mediumwith variable terminology used for similar clinical en-
tities or histologic diagnoses [4]. In this case, searches
need to be highly sensitive to ensure important evidence
is not overlooked, while minimizing the retrieval of non-
relevant articles to ensure efficiency.
Search filters are a logical way to deal with these bar-
riers. Filters are pre-tested searches created by strategic-
ally combining individual and combinations of search
terms to achieve optimal article retrieval for a given pur-
pose. Many filters already exist including those opti-
mized to retrieve studies and systematic reviews of
diagnosis, etiology, treatment, outcomes, adverse events,
prognosis, and clinical prediction guides [5-14]. More
recently, topic-based search filters have started to
emerge [15-17]. Within the area of nephrology, search
filters already exist to retrieve renal information andtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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ever, none of these filters were designed to enhance re-
trieval of articles relevant only to glomerular disease.
A search filter for glomerular disease would allow phy-
sicians to perform searches within a subset of articles in
an online database that were preselected as relevant to
this content area. For example, if a user wanted to deter-
mine the most effective immunosuppressive therapy for
a case of membranous nephropathy, they could combine
the terms ‘treatment membranous’ with the glomerular
disease search filter to improve the precision of article
retrieval. The search filter acts as an optimized substi-
tute for topic-specific terms required to increase the sen-
sitivity and specificity of the search and eliminates the
need to enter these glomerular disease terms and syno-
nyms in the search query (e.g., nephropathy, glomerulo-
pathy, glomerulonephritis). This strategy, in theory,
should maximize the retrieval of articles relevant to
glomerular disease and minimize non-relevant articles,
increasing the overall precision of each search.
We conducted this study to develop and test glomeru-
lar disease search filters for PubMed, Ovid Medline, and
Embase. Afterwards, we did some proof of concept
searches to illustrate the potential effectiveness of these
new filters with real physician searches in the PubMed
database at large.Methods
We used a diagnostic test assessment framework to de-
velop and validate search filters for glomerular disease.
For the purpose of this study, glomerular disease was
defined as any disease in which the glomerulus of the
kidney is affected, resulting in hyperplasia, atrophy, ne-
crosis, scarring, or deposits in the glomeruli.Sample of articles
We first established the reference standard by manual
review of all full text articles published in 39 journals
from 2004 to 2008. To develop this collection of jour-
nals, we adopted a similar strategy for article sampling
as published in prior search filter studies. This approach
has resulted in filters that generalize well over publica-
tion years and journal types [15,19,20]. We compiled a
list of 466 journals from a list of journals that had pub-
lished at least one article relevant to renal care from
1961 to 2005 [21]. We then ranked these journals
according to the number of articles with relevant infor-
mation and selected the top 20 journals. In addition to
this, we selected 19 more journals at random from the
remaining 446 journals. We then randomly divided these
39 journals into development and validation sets at a
ratio of two to one respectively.Article review
We manually reviewed all full text articles indexed in
PubMed, Ovid Medline, and Embase from 2004 to 2008
for each journal in the development and validation set
for relevance to glomerular disease (Additional file 1:
Appendix A). These 22,992 articles included original
investigations, reviews, letters, and editorials. We derived
a standardized checklist of qualifications and terms to
classify articles as relevant to glomerular disease from a
review of nephrology textbooks and the MeSH thesaurus
(Additional file 1: Appendix B). Three readers (AI, CL,
AG) used this checklist to determine whether the full
text of each article was relevant to nephrology. All
reviewers were calibrated against a nephrologist (AG) in
their application of checklist criteria using two test sets
of 100 articles (agreement beyond chance, κ= 0.91).
Filters
We developed unique filters for PubMed, Ovid Medline,
and Embase. We obtained the search terms used for filter
development from the following sources: US National Li-
brary of Medicine (NLM) medical subject heading (MeSH)
thesaurus using Medline MeSH browser [22], Medline per-
muted index [23], Emtree thesaurus [24], SNOMED clin-
ical terms, nephrology textbooks [25], clinical practice
guidelines [26,27], systematic reviews [28-33], website
glossaries, and clinician and librarian opinion. All terms
considered potentially useful by any member of our team
were included. Examples of terms used in the filters in-
clude ‘glomerulonephritis’, ‘proteinuria’, ‘nephrotic’, and ‘bi-
opsy’. We used MeSH terms with or without major focus
and with or without additional subheadings or explosion
capability. Major focus refers to records in which an index
term has been tagged as the major topic of the article.
Entering the exploded MeSH term ‘glomerulonephritis’
means the following terms are also automatically included
in the search: anti-glomerular basement membrane dis-
ease, IgA, membranoproliferative, membranous, focal seg-
mental glomerulosclerosis, and lupus nephritis. We
considered free text words as full and truncated terms
and accounted for both American and British English
spelling. The inclusion of multiple endings was achieved
through the use of the $ symbol (for example, glomerulo$).
Terms could appear anywhere in a citation, but not solely
in the journal name. We repeated the same process for
Embase using EMTREE index terms to replace the MeSH
terms in PubMed and Ovid Medline.
We automated the process of combining and testing
the filters by using a computer-implemented algorithm.
We combined single term filters into multiple term fil-
ters by selectively using the Boolean operators “OR,”
“AND,” and “NOT” to maximize sensitivity and specifi-
city. We then compared the retrieval performance of
various filters (made up of individual and combinations
Hildebrand et al. BMC Medical Informatics and Decision Making 2012, 12:49 Page 3 of 10
http://www.biomedcentral.com/1472-6947/12/49of search terms) with the reference standard from man-
ual review in the development set.Statistical analysis
For each filter, we constructed a two by two contingency
table and assessed filter performance by calculating sen-
sitivity, specificity, precision, and accuracy, similar to
evaluation of a diagnostic test (Table 1). We then
selected filters from the development phase that demon-
strated high performance in either sensitivity or specifi-
city without compromising precision and retested them
in the validation set of articles.Proof of concept searches
To illustrate the potential effectiveness of validated filters
in PubMed, we selected six independent nephrologists
from a directory of Canadian nephrologists provided by
the Royal College of Physicians and Surgeons of Canada
to execute a search for a unique predetermined clinical
question. We formulated six clinical questions, each
which could be answered by a recent corresponding sys-
tematic review [28-33]. These systematic reviews were
then used as a reference source for relevant articles on
the given topic. For example, the question ‘What are the
benefits and harms of different interventions for the
treatment of renal vasculitis in adults?’ was framed to
match a systematic review of thirteen articles on inter-
ventions for renal vasculitis in adults by Walters et al.
[32]. We asked each nephrologist to formulate a search
strategy for the given clinical question without know-
ledge of the search filter or database in use. We then ap-
plied these searches to the PubMed database with and
without the validated filters developed as part of this
study. Search dates were restricted to the date on which
the review was updated. In each case, we noted the num-
ber of relevant articles identified in searches with and





Manual review of each article
Articles relevant to
glomerular disease
Articles not relevant to
glomerular disease
Article identified a b
Article not identified c d
Sensitivity = a/(a + c): proportion of all articles with information on glomerular
disease in the reference set that are retrieved by the filter (also called recall in
information retrieval studies).
Specificity = d/(b + d): proportion of all articles without information on
glomerular disease in the reference set that are correctly not retrieved by the
filter.
Precision = a/(a + b): proportion of all articles retrieved by the filter with
information on glomerular disease (also referred to as positive predictive value
in diagnostic test terminology).
Accuracy = (a + d)/(a + b+ c + d): proportion of all articles dealt with correctly by
filter.standard, which in this case was the set of relevant arti-
cles as determined by each systematic review.
Results
Sample of articles
We used 22,992 full text articles from 39 journals
(Additional file 1: Appendix A). In total, 21,300 articles
contributed to the PubMed set, while 21,280 and 22,158
articles contributed to the Ovid Medline and Embase
set, respectively. We assigned 14,619 articles to the de-
velopment set and 8,373 articles to the validation set.
Single term filters
We tested 261,255 single term filters. The single term
filters with optimal balance of sensitivity and specificity
in the development set were ‘Kidney Diseases[mh]’ for
PubMed (90.2% sensitivity, 87.0% specificity), ‘exp Kid-
ney Diseases/’ for Ovid Medline (90.2% sensitivity, 87.0%
specificity), and ‘exp kidney disease/’ for Embase (95.3%
sensitivity, 80.6% specificity).
Multiple term filters
We tested 736,043 multiple term filters. Our best per-
forming filters for PubMed, Ovid Medline, and Embase
are shown in Table 2, categorized by high-sensitivity and
high-specificity. These filters used over 50 terms. All fil-
ters in the development set achieved 93.8-99.0% sensitiv-
ity, 95.2-98.6% specificity, 43.4-71.1% precision, and
95.3-98.5% accuracy. Filters optimized for sensitivity
achieved 96.7-99.0% sensitivity in the development set
and filters optimized for specificity achieved 98.4-98.6%
specificity (Table 2).
The performance of these filters was consistent in
the validation set. All filters in the validation set
achieved 91.1-96.4% sensitivity, 96.0-98.6% specificity,
and 95.9-98.5% accuracy, however the precision
dropped to 28.5-52.9%. Filters optimized for sensitivity
achieved 94.8-96.4% sensitivity in the validation set
and filters optimized for specificity achieved 98.5-98.6%
specificity (Table 2).
Proof of concept searches
Selected systematic reviews included a range of 3 to 15
relevant articles. Search phrases determined and entered
by the physicians included ‘(mycophenolate OR cyclo-
phosphamide) lupus’, ‘treatment membranous’, ‘steroid
HSP’, ‘renal vasculitis treatment limit to English, core
journals, adults’, ‘low protein diet diabetes’, and ‘minimal
change treatment’. In all proof of concept searches using
the validated high-sensitivity filter, the number of non-
relevant articles was minimized without compromising
the retrieval of relevant articles (Table 3). In proof of
concept searches using the validated high-specificity fil-
ter, there was a more dramatic reduction in non-relevant
Table 2 Glomerular Disease Search Filters for PubMed, Ovid Medline, and Embase Optimized for High Sensitivity and High Specificity
Set Sensitivity (%) Specificity (%) Precision (%) Accuracy (%)




(nephropath*[tw] OR glomerulonephrit*[tw] OR proteinuri*[tw] OR nephrotic[tw] OR
glomerulosclerosis[tw] OR nephrit*[tw] OR kidney biopsy[tiab] OR renal biopsy[tiab] OR
albuminuri*[tw] OR glomerulopath*[tiab] OR membranoproliferative[tw] OR
mesangioproliferative[tiab] OR nephrosis[tw] OR microalbuminuri*[tiab] OR diabetic kidney[tw]
OR diabetic renal[tw] OR anti-glomerular[tw] OR nephrosclerosis[tiab] OR alport*[tw] OR
goodpasture*[tiab] OR minimal change[tiab] OR glomerular disease*[tiab] OR anca*[tw] OR
anti-neutrophil[tw] OR polyangiitis[tw] OR polyangitis[tw] OR antineutrophil[tw] OR
antiglomerular[tw] OR "Kidney Glomerulus"[majr:noexp] OR "Lupus Erythematosus,
Systemic"[majr:noexp] OR "Vasculitis"[majr:noexp] OR "Purpura, Schoenlein-Henoch"[mh:noexp]
OR "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis"[mh] OR ((lupus[tw] OR
vasculitis[tw] OR purpura[tw] OR granulomatosis[tw]) AND (glomerul*[tw] OR kidney[tw]
OR renal[tw] OR nephrolog*[tw])) OR ((chronic kidney[tiab] OR chronic renal[tiab]
OR "Renal Insufficiency, Chronic"[mh]) AND ("Diabetes Mellitus, Type 2"[majr:noexp] OR
"Kidney Glomerulus"[mh:noexp])) OR ("Kidney Diseases"[majr] AND (biopsy[tw] OR
myeloma[tiab] OR renin-angiotensin[tw] OR hiv[tiab] OR amyloid*[tw])))
Development 96.7 (95.1-98.3) 95.2 (94.9-95.6) 43.4 (40.4-46.3) 95.3 (94.9-95.7)
Validation 94.8 (91.1-98.6) 96.0 (95.5-96.4) 28.5 (24.3-32.7) 95.9 (95.5-96.4)
High-Specificity
Filter
(glomerulonephrit*[tw] OR nephrotic[tw] OR diabetic nephropath*[tw] OR glomerulosclerosis[tw]
OR iga nephropath*[tiab] OR minimal change[tiab] OR membranoproliferative[tw] OR
glomerulopath*[tiab] OR membranous nephropathy[tiab] OR antineutrophil[tw] OR nephrosis[tw]
OR anca*[tw] OR diabetic kidney[tiab] OR anti-glomerular[tw] OR glomerular disease*[tiab]
OR anti-neutrophil[tw] OR antiglomerular[tw] OR polyangiitis[tw] OR alport*[tw] OR
mesangioproliferative[tiab] OR goodpasture*[tiab] OR immunoglobulin a nephropathy[tiab] OR
"AIDS-Associated Nephropathy"[majr:noexp] OR "Purpura, Schoenlein-Henoch"[majr:noexp]
OR "Nephritis, Hereditary"[majr:noexp] OR "Anti-Neutrophil Cytoplasmic Antibody-Associated
Vasculitis"[majr] OR "Balkan Nephropathy"[majr:noexp] OR (diabet*[ti] AND nephropath*[ti]) OR
((kidney[tw] OR renal[tw] OR nephrit*[tw] OR nephrolog*[tw] OR glomerul*[tw]) AND (purpura[tw]
OR lupus[tw] OR vasculitis[tw])) OR ((nephrit*[tw] OR "Renal Insufficiency, Chronic"[mh] OR chronic
kidney[tiab] OR chronic renal[tiab]) AND ("Kidney Glomerulus"[mh:noexp] OR "Diabetes Mellitus,
Type 2"[majr:noexp] OR microalbuminuri*[tiab] OR immunoglobulin[tiab])) OR ((proteinuri*[ti] OR
"Proteinuria"[majr:noexp]) AND (hematuria[tw] OR haematuria[tiab] OR glomerulo*[tw] OR
amyloid*[tw] OR albuminuri*[tiab] OR inflammation[tiab] OR myeloma[tw])) OR ((glomerulo*[tw]
OR nephropath*[tiab] OR proteinuri*[ti] OR microalbuminuri*[ti] OR albuminuri*[ti]) AND
("Diabetes Mellitus, Type 2"[majr:noexp] OR "Diabetic Angiopathies"[majr] OR overt[tiab])) OR
("Kidney Diseases"[majr:noexp] AND (amyloid*[tw] OR mesangio*[tiab] OR sclerosis[tiab])))
Development 93.8 (91.6-95.9) 98.4 (98.2-98.6) 69.2 (65.6-72.7) 98.3 (98.0-98.5)




(nephropath$.mp OR glomerulonephrit$.mp OR proteinuri$.mp OR nephrotic.mp OR
glomerulosclerosis.mp OR nephrit$.mp OR renal biopsy.tw OR albuminuri$.mp OR minimal
change.tw OR glomerulopath$.tw OR membranoproliferative.mp OR antineutrophil.mp OR
glomerular disease$.tw OR nephrosis.mp OR microalbuminuri$.tw OR anca$.mp OR (diabetic adj
(kidney or renal)).mp OR kidney biopsy.tw OR anti-glomerular.mp OR antiglomerular.mp
OR anti-neutrophil.mp OR polyang?itis.mp OR alport$.mp OR mesangioproliferative.tw OR
goodpasture$.tw OR nephrosclerosis.tw OR *Kidney Glomerulus/ OR *Lupus Erythematosus,
Systemic/ OR *Vasculitis/ OR Purpura, Schoenlein-Henoch/ OR exp Anti-Neutrophil Cytoplasmic

























Table 2 Glomerular Disease Search Filters for PubMed, Ovid Medline, and Embase Optimized for High Sensitivity and High Specificity (Continued)
Antibody-Associated Vasculitis/ OR ((glomerul$.mp OR kidney.mp OR renal.mp OR nephrolog$.mp)
AND (lupus.mp OR purpura.mp OR vasculitis.mp OR granulomatosis.mp)) OR ((chronic adj2
(kidney or renal)).mp AND (*Diabetes Mellitus, Type 2/ OR Kidney Glomerulus/)) OR (exp *Kidney
Diseases/ AND (biopsy.mp OR myeloma.tw OR renin-angiotensin.mp OR hiv.tw OR amyloid$.mp)))
Validation 94.8 (91.1-98.6) 96.0 (95.5-96.4) 28. 6 (24.4-32.8) 96.0 (95.5-96.4)
High-Specificity
Filter
(glomerulonephrit$.mp OR (diabetic adj (nephropath$ or kidney)).mp OR nephrotic.mp OR
glomerulosclerosis.mp OR iga nephropath$.tw OR minimal change.tw OR glomerulopath$.tw OR
membranous nephropathy.tw OR membranoproliferative.mp OR antineutrophil.mp OR glomerular
disease$.tw OR nephrosis.mp OR anca$.mp OR anti-glomerular.mp OR anti-neutrophil.mp OR
antiglomerular.mp OR polyang?itis.mp OR alport$.mp OR mesangioproliferative.tw OR
goodpasture$.tw OR immunoglobulin a nephropathy.tw OR *AIDS-Associated Nephropathy/
OR *Purpura, Schoenlein-Henoch/ OR *Nephritis, Hereditary/ OR exp *Anti-Neutrophil Cytoplasmic
Antibody-Associated Vasculitis/ OR *Balkan Nephropathy/ OR (diabet$ AND nephropath$).ti
OR ((glomerul$.mp OR kidney.mp OR renal.mp OR nephrit$.mp OR nephrolog$.mp) AND (lupus.mp
OR vasculitis.mp OR purpura.mp)) OR ((nephrit$ OR (chronic adj2 (kidney or renal))).mp. AND
(Kidney Glomerulus/ OR *Diabetes Mellitus, Type 2/ OR microalbuminuri$.tw. OR
immunoglobulin.tw.)) OR ((proteinuri$.ti OR *Proteinuria/) AND (glomerulo$.mp OR h?ematuria.mp
OR albuminuri$.tw OR inflammation.tw OR amyloid$.mp OR myeloma.mp)) OR ((glomerulo$.mp
OR nephropath$.tw OR proteinuri$.ti OR microalbuminuri$.ti OR albuminuri$.ti) AND
(*Diabetes Mellitus, Type 2/ OR exp *Diabetic Angiopathies/ OR overt.tw)) OR (*Kidney Diseases/
AND (amyloid$.mp OR mesangio$.tw OR sclerosis.tw)))
Development 93.8 (91.6-95.9) 98.4 (98.2-98.6) 69.2 (65.6-72.7) 98.3 (98.0-98.5)





(exp glomerulopathy/ OR ((kidney or renal) adj biopsy).mp OR (diabet$ adj (kidney or renal or
nephr$)).mp OR nephrotic.tw OR nephrotic syndrome/ OR glomerulonephrit$.tw OR
immunoglobulin a nephropathy/ OR glomerul$ basement membrane$.mp OR iga
nephropath$.tw OR minimal change.mp OR membranoproliferative.mp OR (glomerul$ adj
(nephr$ or disease$ or scleros$)).tw OR membranous nephr$.tw OR anca$.mp OR
proliferative glomerulonephritis/ OR wegener granulomatosis/ OR antineutrophil.mp OR
polyang?itis.mp OR *glomerulus/ OR anaphylactoid purpura/ OR alport$.mp OR hiv-associated
nephropath$.tw OR anti-neutrophil.mp OR mesangioproliferative.mp OR goodpasture$.mp
OR (balkan adj2 nephr$).mp OR heymann nephritis/ OR ((lupus.mp OR vasculit$.mp OR
purpur$.mp OR hiv$.tw OR granulomatosis.mp) AND ("Urology and nephrology".ec OR
proteinuri$.mp OR nephrit$.mp)) OR ((exp *diabetes mellitus/ OR diabet$.ti) AND
(nephropath$.tw OR exp *proteinuria/ OR renin-angiotensin$.mp OR dialys$.tw OR *kidney
failure/ OR ((kidney OR renal) adj disease$).ti OR h?emodialys$.tw)) OR (exp *kidney disease/
AND (nephropath$.ti OR exp *proteinuria/ OR renin-angiotensin$.mp OR proteinuri$.ti OR
amyloid$.mp)) OR ((exp proteinuria/ OR proteinuri$.mp) AND (nephropath$.tw OR nephrit$.mp
OR renin-angiotensin$.tw)))
Development 9.0 (98.1-99.9) 95.3 (94.9-95.6) 43.4 (40.5-46.3) 95.4 (95.1-95.8)

























Table 2 Glomerular Disease Search Filters for PubMed, Ovid Medline, and Embase Optimized for High Sensitivity and High Specificity (Continued)
High-Specificity
Filter
(exp *glomerulopathy/ OR nephrotic.tw OR glomerulonephrit$.tw OR diabetic nephropath$.tw
OR *diabetic nephropathy/ OR glomerul$ basement membrane$.mp OR nephrotic syndrome/
OR *immunoglobulin a nephropathy/ OR iga nephropath$.tw OR minimal change.mp OR
membranoproliferative.tw OR membranous nephropathy.tw OR anca$.mp OR proliferative
glomerulonephritis/ OR antineutrophil.mp OR polyang?itis.mp OR *glomerulus/ OR alport$.mp
OR hiv-associated nephropath$.tw OR anti-neutrophil.mp OR *anaphylactoid purpura/ OR
*wegener granulomatosis/ OR goodpasture$.tw OR mesangioproliferative.tw OR (balkan adj2
nephr$).tw OR ((lupus.mp OR vasculit$.tw OR granulomatosis.mp OR purpur$.tw OR
amyloid$.tw) AND (kidney biopsy/ OR proteinuri$.mp OR nephrit$.mp OR serum creatinine.tw))
OR ((exp *diabetes mellitus/ OR proteinuri$.ti OR *proteinuria/) AND (exp glomerulopathy/
OR nephropath$.tw OR *kidney failure/ OR ((kidney or renal) adj disease$).ti OR
*microalbuminuria/)) OR ((exp glomerulopathy/ OR diabetic nephropath$.mp) AND
(kidney biopsy/ OR mesangial$.tw OR angiotensin$.tw OR serum creatinine.tw OR
albuminuri$.mp OR microalbuminuri$.mp)))
Development 95.7 (93.9-97.5) 98.6 (98.4-98.8) 71.1 (67.6-74.6) 98.5 (98.3-98.7)
Validation 92.8 (88.5-97.1) 98.6 (98.3-98.8) 52.9 (46.6-59.1) 98.5 (98.2-98.7)
{ PubMed fields: * = truncation character; [tw] = text word present in title, abstract, or MeSH term; [tiab] = term present in title or abstract; [majr:noexp] = not exploded and focused MeSH term; [mh:noexp] = non-
exploded MeSH term; [mh] = exploded MeSH term; [majr] = exploded and focused MeSH term; [ti] = term present in title.
† Medline fields: $ = truncation character; mp=multiple posting (term appears in title, abstract, or MeSH); tw= text word present in title; /=MeSH character; adj = adjacent operator; * = focused MeSH term;
adj2 = defined adjacency operator; exp = exploded MeSH term; ? = optional wildcard; ti = term present in title.R
Embase fields: exp = exploded EMTREE term; /=EMTREE character; adj = adjacent operator; $ = truncation character; mp=multiple posting (term appears in title, abstract, or EMTREE); tw = term present in title or

























Table 3 Proof-of-concept searches showing the number of relevant articles retrieved with and without glomerular disease filter
Clinical Question* Physician search alone Physician search with the
high-sensitivity filter















What are the efficacy and safety of mycophenolate
mofetil (MMF) and cyclophosphamide (CYC) in the
treatment of proliferative lupus glomerulonephritis
(GN)? (7 relevant articles) [29]
2006 7 1721 7 1080 7
Is immunosuppressive treatment effective and
safe in the treatment of idiopathic membranous
nephropathy (IMN) in adults with nephrotic
syndrome? (15 relevant articles) [30]
87500 15 3231 15 2687 15
Does corticosteroid therapy ameliorate the acute
manifestations of Henoch-Schonlein purpura or
mitigate renal injury? (15 relevant articles) [31]
393 5 68 5 65 5
What are the benefits and harms of different
interventions for the treatment of renal vasculitis
in adults? (13 relevant articles) [32]
34741 8 8455 8 5923 8
What is the effect of a low-protein diet (LPD) on
renal function in patients with type 1 or 2
diabetic renal diseases? (8 relevant articles) [33]
868 7 207 7 180 6
What are the benefits and harms of interventions
for the nephrotic syndrome in adults caused
by minimal change disease? (3 relevant articles)
[28]
4662 3 1236 3 1203 3
* The search phrases as determined and typed in by physicians were: ‘(mycophenolate OR cyclophosphamide) lupus’, ‘treatment membranous’, ‘steroid HSP’, ‘renal vasculitis treatment limit to english, core journals,
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retrieved using the search ‘low protein diet diabetes’
(Table 3).
Discussion
Building on the same concepts our group has used to
create novel high performance search filters for general
nephrology and renal transplantation [15,18], we have
succeeded in developing and validating search filters for
glomerular disease that are highly sensitive and specific.
All filters achieved a balance of at least 93.8% sensitivity
and specificity. Our best performing high-sensitivity fil-
ter was in Embase, achieving 99.0% sensitivity and 95.3%
specificity. The best performing high-specificity filter
was also in Embase, which reached 95.7% sensitivity and
98.6% specificity. Without changing their PubMed
search terms, in an illustrative example physicians were
able to retrieve articles with a higher degree of precision
(less non-relevant articles) with use of these filters.
These filters are complex, often combining in excess
of 50 terms with Boolean operators. Coding these filters
into the PubMed and Ovid search engine interfaces
will permit their easy use by anyone doing a search. In
the meantime, we provide these filters at the following
link: http://hiru.mcmaster.ca/hiru/hiru_hedges_nephrology_
filters.aspx. As of September 2011, use of the high-
sensitivity glomerular disease filter reduced the PubMed
database from 21 million to 195,374 articles, and the
high specificity filter reduced this to 107,658 articles.
Depending on the search terms entered by the user,
these filters may serve many purposes, which are best
understood in the context of our illustrative proof of
concept searches (Table 3). First, without changing the
original search term(s), selecting a filter applies the
search only to a subset of articles that are richer in
glomerular disease content. The result is an increase in
precision of the search, similar to the increase in positive
predictive value of a screening test when applied to a
high-risk population. This was demonstrated by the use
of search terms ‘minimal change treatment’ in Table 3.
Fewer non-relevant articles were retrieved with use of
the filter (1236 versus 4662 articles), without impacting
relevant article retrieval. Second, the filter acts as an
optimized substitute for glomerular disease specific
terms and synonyms allowing users to simplify the search
query. This avoids unnecessarily limiting the search due
to indexing inconsistencies inherent with the termin-
ology used to define glomerular disease. For example, if a
user was searching for dietary recommendations in dia-
betic nephropathy, the search terms may be simplified to
‘low protein diet diabetes’, instead of searching for ‘low
protein diet diabetes’ with selected terms such as
‘nephropathy’, ‘kidney disease’, or ‘glomerulosclerosis’ that
may negatively impact relevant article retrieval. In thiscase, even without use of search terms pertaining to
glomerular disease, precision of the results was enhanced
(Table 3). Third, users may opt to exclude disease specific
terms entirely and use the filter to address questions
that potentially relate to all glomerular disease equally.
An example of this may include entering ‘immunization’
when addressing the impact of vaccinations in patients
with glomerular disease.
Our results also highlight that even with high perform-
ance validated search filters, a single search will rarely
retrieve everything of relevance on a particular topic.
There is simply too much variation in the quality of ac-
companying search terms entered by the user, complete-
ness of the database, and quality and consistency of
indexing. This explains why in some proof of concept
searches, retrieval of relevant articles was incomplete
both with and without use of the filter (Table 3). Also,
the extent to which the search filter is generalizable
depends upon the sample of journals selected for study
and the method by which articles were defined as rele-
vant. Our selection of journals was deliberately enriched
with leading clinical nephrology journals. Although it
also included a random sampling of other journals, this
set of journals may not adequately represent the
complete set of multi-disciplinary journals that feature
glomerular disease content in PubMed. This may explain
the significant drop in precision when the filter was ap-
plied to the validation set, which was a smaller database
by design with a lower proportion of relevant articles.
Our choice to divide articles into the development and
validation sets at the journal level may have also contrib-
uted to the lower proportion of articles with glomerular
disease content in the validation set. However, this ap-
proach provided insight as to what would occur if the
search database were expanded to include the over 5000
journals indexed in PubMed.
Proof of concept searches were used to illustrate the
functionality of our best performing filters with real
physician searches. In each case, the clinical questions
formulated from recent systematic reviews were relevant
to glomerular disease and physician searches appear typ-
ical for the average user. These examples show a gain in
search strategy precision with use of the high-sensitivity
and high-specificity filter through a dramatic reduction
in non-relevant articles. This occurs without sacrificing
retrieval of relevant articles in most cases. However, the
methods for defining the reference standard based on
articles used in systematic reviews of variable quality is
indirect and has not been compared with one derived
from hand searching [34]. For this reason the proof of
concept searches should be viewed as illustrative exam-
ples, not as evidence of further filter validation.
These search filters for glomerular disease were
designed to offer physicians and researchers a strategy to
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on the level of article retrieval they deem manageable on
a practical level. Filters that maximize sensitivity involve
a compromise on the level of precision achieved, though
this still may appeal to a researcher conducting a sys-
tematic review. For busy physicians at the point of care,
we recommend starting with the high-specificity filter.
To narrow results even further, physicians may prefer
use these search filters in conjunction with previously
developed methods filters, such as the therapy filter for
randomized controlled trials available via PubMed’s
Clinical Queries section [5-14]. This approach has not
been formally tested with the glomerular disease filters,
but in a recent study has been shown to increase the ef-
ficiency of retrieval of articles relevant to renal care [35].Conclusions
In conclusion, we have succeeded in developing and val-
idating high performance search filters for glomerular
disease that can be easily applied by the busy physician.
We expect this will contribute to more efficient and ef-
fective evidence-based decision-making, education, and
patient care. Future research is required to measure this
impact, and to better understand the usefulness of these
filters when used in combination with previously devel-
oped methods filters for physician searches.Additional file
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